SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

Article citations

More>>

Rieger, M., Kochleus, C., Teschner, D., et al. (2014) A New ELISA for the Quantification of Equine Procalcitonin in Plasma as Potential Inflammation Biomarker in Horses. Analytical and Bioanalytical Chemistry, 406, 5507-5512.
http://dx.doi.org/10.1007/s00216-014-7944-z

has been cited by the following article:

  • TITLE: Procalcitonin—A Useful Biomarker for Pneumonia Associated with Rhodococcus equi?

    AUTHORS: Ann Kristin Barton, Martin Rieger, Dana Teschner, Heidrun Gehlen

    KEYWORDS: Foal, Horse, Lung, Pneumonia, Procalcitonin, Rhodococcus equi

    JOURNAL NAME: Modern Research in Inflammation, Vol.5 No.2, May 11, 2016

    ABSTRACT: Background: Procalcitonin, a precursor protein of the hormone calcitonin, is a sensitive marker for sepsis in human medicine, which is used for diagnosis of bacterial pneumonia in adults and neonates to initiate antibiotic therapy. Objectives: In this study, procalcitonin was evaluated as a potential biomarker for Rhodococcus equi associated pneumonia. Methods: In four foals procalcitonin was measured at four time-points (day 0 before antibiotic therapy, day 1, 3 and 5/6 during therapy) in plasma using an equine specific ELISA. Inclusion criteria for the study were a positive sepsis score, ultrasonographic evidence of pulmonary abscesses in addition >8 cm, a positive microbiology out of tracheobronchial secretion and positive response to antibiotic treatment (azithromycin 10 mg/kg BDW 24q PO and rifampicin 10 mg/kg BDW 12q PO) within a weak including improvement of clinical status and reduction of ultrasonographic score Rhodococcus equi.